Condition: Atrial Fibrillation - Symptomatic · Sponsor: Cardioangiologisches Centrum Bethanien
This is a prospective, randomized (1:1), pilot study enrolling 200 patients with symptomatic atrial fibrillation or atrial tachycardia (AF/AT) recurrence requiring repeat ablation following a single prior PVI procedure for AF.
This description comes directly from the study's public registry record.
Julian Chun, Professor · +49 69 945028 · j.chun@ccb.de
Boris Schmidt, Professor · +49 69 945028 · b.schmidt@ccb.de
Always discuss trial participation with your own doctor first.
| Cardioangiologisches Centrum Bethanien, Frankfurt am Main, 60431 | Frankfurt am Main, Hesse, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07390214